T
10x Genomics TXG
$58.19
−1.54%
Nov 13
1W
1M
3M
6M
1Y
3Y
5Y
Activities
Key indicators
Sales
−4%
$619M over 12 months
Net margin
−12%
Low
High
Volatility
78%
Calm
Choppy
Bars: against the 7 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about TXG yet.
About 10x Genomics, Inc. Class A Common Stock
10x Genomics sells instruments, single-use consumable kits and software for single cell and spatial biology, which let researchers study individual cells and where genes are active in tissue. Most revenue comes from consumables that customers reorder, sold to academic labs and biopharma companies. It still loses money and funds itself from a cash pile.